Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (7): 727-731.

Previous Articles     Next Articles

Comparison of the inhibitory effect on HBV replication by siRNA and lamivudine in HepG2.2.15 cells

LI Gui-qiu, CHEN Shu-lan, CUI Lan-ying, ZHAO Jin-ying, LUO Wen-tao, LU Juan   

  1. Division of Microbiology, the First Clinical College of Harbin Medical University, Harbin 150081,Heilongjiang,China
  • Received:2010-05-04 Revised:2010-06-15 Online:2010-07-26 Published:2020-09-15

Abstract: AIM: To compare the inhibitory effect of inhibition of siRNA and lamivudine on hepatitis B virus replication and expression in HepG2.2.15 cells.METHODS: Recombinant plasmid psil-HBV was constructed and transfected into HepG2.2.15 cells. The transfected cells were harvested at 48,72 and 96 h. The concentration of HBeAg and HBsAg was determined using ELISA method. HBV DNA replication was examined by real time PCR, and the level of HBV mRNA was measured by reserved transcribed PCR.RESULTS: siRNA effectively inhibited the expressing and replication of HBV at the levels of HBsAg, HBV DNA and mRNA(P<0.05). Lamivudine had only inhibitory effect on viral DNA synthesis.CONCLUSION: The anti-HBV effect of HepG2.2.15 cells treated by siRNA is totally differently and more effective from that seen with lamivudine in HepG2.2.15 cells.

Key words: Hepatitis B virus, siRNA, Lamivudine, HepG2.2.15 cell

CLC Number: